VIEW PRESS RELEASE [PDF] 01 SEPT 2011: Cleveland OH – Great Lakes NeuroTechnologies was recently awarded two NIH SBIR grants: $1.7 million in Phase II funding from the National Institute on Aging to develop ETSense ™, an adaptive, portable essential…
Blog Archives
PRESS RELEASE: Great Lakes NeuroTechnologies Receives Nearly $2 Million In New Funding To Expand Home-Based Technologies For Monitoring Movement Disorders
Tagged with: baylor college of medicine, essential tremor, et, funding, kinesia, nih, parkinson's disease, rush university medical center, sbir, tremor
PRESS RELEASE: The University of Rochester and Great Lakes NeuroTechnologies launch new clinical study to develop ambulatory dyskinesia assessment system
VIEW PRESS RELEASE [PDF] Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology will be used in a clinical study to capture and quantify dyskinesias (involuntary, irregular movements) caused by Parkinson’s disease (PD) medication. PD…
PRESS RELEASE: Great Lakes NeuroTechnologies’ KinetiSense technology used in Parkinson’s disease gait and balance study
VIEW PRESS RELEASE [PDF] Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology was used in a clinical study to capture and quantify the effect of Deep Brain Stimulation (DBS) on gait and balance impairment…
PRESS RELEASE: Great Lakes NeuroTech’s BioRadio and Vivonoetic Inc.’s VivoSense Used in Prematurity and Respiratory Outcomes Program Multicenter Study
VIEW PRESS RELEASE [PDF] Cleveland, OH – August 1, 2011 – Great Lakes NeuroTech’s BioRadio and Vivonoetics Inc.’s VivoSense software are being used for the Prematurity and Respiratory Outcomes Program (PROP, http://www.urmc.rochester.edu/pediatrics/pedsnews/july-10/prop.cfm) multicenter clinical study to examine the respiratory outcome…
Tagged with: bioradio, clinical study, data analysis, infant, nih, physiological monitor, plethysmography, premature, prop, respiratory disease, respiratory outcome, rip, state university of new york, university of california, university of north carolina, university of rochester, university of washington, vanderbilt university, vivonoetics, vivosense, wireless respiration
PRESS RELEASE: Cleveland Medical Devices Inc. spins off Great Lakes NeuroTechnologies
VIEW PRESS RELEASE [PDF] Cleveland, OH – March 23, 2011 – Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTechnologies (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor…
PRESS RELEASE: CLEVEMED ASSISTS AMERICAN MEDICAL ASSOCIATION IN RELEASE OF CPT CODE FOR RECORDING PHYSIOLOGIC TREMOR
VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO (April 25, 2009) – The American Medical Association (AMA) CPT® Editorial Panel approved the release of Category III CPT code 0199T for physiologic recording of tremor using accelerometer(s) and gyroscope(s), (including frequency and amplitude)…
Tagged with: ama, category iii cpt, efficacy, evaluation, kinesia, motor sumptom, movement disorder, symptom severity, telemedicine, tremor, wireless
PRESS RELEASE: CLEVEMED ISSUES ONLINE UPDRS SCORING CHALLENGE TO HIGHLIGHT BENEFITS OF KINESIA™ AUTOMATED TREMOR SCORING
VIEW PRESS RELEASE [PDF] CLEVELAND, Ohio (March 24, 2009) – Cleveland Medical Devices Inc. (CleveMed) announced the release of automated tremor scoring for Kinesia™, a compact patient worn device for assessing Parkinson’s disease (PD) motor symptom severity. To demonstrate the…
PRESS RELEASE: CLEVEMED LAUNCHES CLINICIAL STUDY MONITORING PARKINSON’S DISEASE MOTOR SYMPTOMS IN THE CLINIC AND AT HOME USING KINESIA™
VIEW PRESS RELEASE [PDF] CLEVELAND, Ohio (January 28, 2009) – Cleveland Medical Devices Inc. (CleveMed) has launched a large scale multicenter clinical study to continue development and validation of Kinesia™, a compact wireless system for monitoring severity of Parkinson’s disease…
Tagged with: bradykinesia, clinical study, dyskinesia, kinesia, motion sensor, motor symptoms, parkinson's disease, pd, telemedicine, tremor, validation, wireless
PRESS RELEASE: CLEVEMED RECEIVES $1.23 MILLION IN NIH FUNDING TO DEVELOP A SYSTEM TO AUGMENT DEEP BRAIN STIMULATION PROGRAMMING IN PARKINSON´S DISEASE
VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO, OCT 7, 2008 – Cleveland Medical Devices Inc. (CleveMed) announced it has been awarded $1.23 million in NIH SBIR FastTrack funding from the National Institute on Aging to develop ParkinTune™, a system to augment…
Tagged with: bradykinesia, cleveland clinic foundation, dbs, deep brain stimulation, efficacy, funding, kinesia, nih, parkinson's disease, pd, rigidity, tremor, updrs
PRESS RELEASE: FROST & SULLIVAN LAUDS CLEVEMED FOR KINESIA™, A REVOLUTIONARY MOBILITY DISORDER MONITORING SYSTEM
VIEW PRESS RELEASE [PDF] Palo Alto, Calif. – March 12, 2008 – Based on its recent analysis of the mobility disorder monitoring systems market, Frost & Sullivan recognizes Cleveland Medical Devices Inc. (CleveMed) with the 2008 North American Product Innovation…
Tagged with: bradykinesia, company, development, essential tremor, et, growth, kinesia, motor assessment, motor symptoms, parkinson's disease, pd